Merck Says It Paid $573M To Settle Zetia Antitrust Case
By Ivan Moreno · April 27, 2023, 8:51 PM EDT
Pharmaceutical giant Merck & Co. Inc. paid $573 million to settle antitrust claims this month over allegations it conspired with Glenmark Pharmaceuticals to delay the launch of generic versions of the blockbuster...
To view the full article, register now.